The mortality rate for malignant neoplasms (male deaths) in Sweden has been forecasted from 2024 to 2028. As of 2023, this value stood at 12.08 thousand deaths. Forecasted data shows a gradual increase each year, demonstrating a consistent uptick in mortality rates. From 2024 to 2025, the increase is 0.33%, from 2025 to 2026, it is 0.25%, and from 2026 to 2027 the increase is 0.33%. The forecast continues this trend, with the period from 2027 to 2028 showing a similar increase of 0.25%, resulting in a Compound Annual Growth Rate (CAGR) of approximately 0.33% over the five-year period.
Future trends to watch for include the potential impact of medical advancements, policy changes, and public health initiatives on mortality rates. Additionally, demographic shifts and lifestyle changes may also influence these trends, either positively or negatively. Monitoring these factors can help anticipate further changes in the mortality rate for malignant neoplasms in Sweden.
